-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Encinosa.pdf
January 01, 2003 - all of the patient’s medical claims for
hospital care, inpatient physician care, outpatient care, drugs … Medstat
Group, Inc., and contains claims data for inpatient care, outpatient care, and
prescription drugs
-
www.ahrq.gov/news/newsletters/e-newsletter/961.html
June 01, 2025 - Comparative effectiveness and safety of the JAK Inhibitors and biologic disease-modifying antirheumatic drugs
-
www.ahrq.gov/news/newsletters/e-newsletter/936.html
November 01, 2024 - Health Care (EHC) Program , which conducts evidence reviews to inform healthcare decision-making on drugs
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/perinatal/0085-tech-specs.pdf
January 01, 2012 - Behavioral Health Risk Assessment for Pregnant Women Measure Technical Specifications
Text Description for PCPI eSpecification
Copyright 2012 American Medical Association and the National Committee for Quality Assurance. All rights reserved.
Clinical Topic Maternity Care
Measure Title Behavioral Health Risk…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/0085textdesc.pdf
January 01, 2012 - Clinical Topic
Text Description for PCPI eSpecification
Copyright 2012 American Medical Association and the National Committee for Quality Assurance. All rights reserved.
Clinical Topic Maternity Care
Measure Title Behavioral Health Risk Assessment
Measure # MC-3
Measure
Description
Percentage of pati…
-
www.ahrq.gov/sites/default/files/2024-02/green-report.pdf
January 01, 2024 - Opioids are the most common drugs involved in overdose death,2 with the majority being prescription … gauge the pharmacy’s level of comfort
and confidence in interacting with patients who may be using drugs … Our
project suggests that pharmacies reach people who inject drugs and communities with emerging drug … Emergency department visits involving nonmedical use of
selected prescription drugs - United States,
-
www.ahrq.gov/sites/default/files/wysiwyg/patient-safety/settings/hospitals/red-toolkit/postdiscalldoc.pdf
June 02, 2025 - 1
Postdischarge Followup Phone Call Documentation Form
Patient name: __________________________________________________________________
Caregiver(s) name(s): ____________________________________________________________
Relationship to patient: __________________________________________________________
Notes:…
-
www.ahrq.gov/sites/default/files/2024-02/taber-report.pdf
January 01, 2024 - Final Progress Report: Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program
Improving Transplant Med Safety through a Pharmacist-Led, mHealth-Based Program
Principal Investigator: David J. Taber, PharmD, MS, BCPS
Professor
Medical University of South Carolina
Department of Surgery
96 J…
-
www.ahrq.gov/sites/default/files/2024-01/wessell-report.pdf
January 01, 2024 - Final Progress Report: Dissemination of the PPRNet Model for Improving Medication Safety
1. TITLE PAGE
Final Progress Report
Dissemination of the PPRNet Model for Improving Medication Safety
Principal Investigator: Andrea M. Wessell, PharmD
Team Members: Steven M. Ornstein, MD
Ruth G. Jenkins, PhD
Lynne S. Neme…
-
www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-family-engagement/pfeprimarycare/medmanagement_webinar_slides.pdf
January 01, 2015 - Medication Management
1
Medication Management
AHRQ
Guide to Improving Patient Safety in Primary
Care Settings by Engaging Patients and
Families
Speaker
Kelly Smith, PhD
Scientific Director, Quality & Safety
Co-PI, AHRQ Guide to Improve Patient Safety
in Primary Care Settings by Engaging
Patients …
-
www.ahrq.gov/sites/default/files/wysiwyg/news/events/nac/2022-05-nac/nacmtg051222-minutes.pdf
January 01, 2022 - It partners with the Food and Drug Administration to
ensure that drugs and devices are safe for use … Data on infused drugs are also not captured in a rigorous way. Dr.
-
www.ahrq.gov/funding/grantee-profiles/index.html
June 01, 2025 - AHRQ Grantee Profiles
These profiles highlight AHRQ grantees whose work has led to significant changes in healthcare policy and influenced research and practice. AHRQ supports a range of research, conference, and career development grant programs that help emerging health services researchers better understand,…
-
www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/NCINQTobaccoUseHelp-References.pdf
August 01, 2012 - National Collaborative for Innovation in Quality Measurement
Tobacco Use and Help
List of References
Campaign for Tobacco-Free Kids. 2012. Tobacco Overview.
http://www.tobaccofreekids.org/facts_issues/tobacco_101/ (April 2012).
Campaign for Tobacco-Free Kids. 2011. Health Harms from Smoking and Other Tobac…
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/infusion-pumps-1.pdf
March 01, 2020 - medication errors are mistakes related to ordering, transcribing, dispensing, administering, or
monitoring drugs … The authors found that the aggregate number of severe harms averted (defined as
high risk drugs being
-
www.ahrq.gov/sites/default/files/wysiwyg/npsd/npsd-portfolios-summary-profile-2014.pdf
January 01, 2014 - For example, 77 drugs reviewed had
Data collection in a standardized format is key to
aggregation … 470 unique formulations for 147 drug entities were
reduced to 104 different concentrations for 100 drugs
-
www.ahrq.gov/sites/default/files/wysiwyg/data/infographics/hac-rates-decline.pdf
June 02, 2025 - Declines in Hospital Acquired Conditions
Declines in Hospital-
Acquired Conditions
National efforts to reduce hospital-acquired conditions such
as adverse drug events and injuries from falls helped prevent
8,000 deaths and saved $2.9 billion between 2014 and 2016.
Adverse
Drug
Events CAUTI*
*CAUTI - Catheter-…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-143-section-5a-evidence-table.pdf
January 01, 2014 - Operative
AEs comprised 44.9% of the total AEs,
while drugs, especially antibiotics and
cardiovascular
-
www.ahrq.gov/sites/default/files/wysiwyg/research/findings/making-healthcare-safer/mhs3/anticoagulants-1.pdf
March 01, 2020 - The review by the Canadian Agency for
Drugs and Technologies in Health (2011) also examined what they … Canadian Agency for Drugs and Technologies in Health. CADTH Health Technology Assessments. … Ottawa: Canadian Agency for Drugs and Technologies in Health; 2011.
2. … risks of thrombotic and hemorrhagic adverse events is
required for NOACs, just as it is for older drugs … Am J Cardiovasc Drugs. 2017;17(6):475-9. doi: 10.1007/s40256-017-
0243-2.
-
www.ahrq.gov/sites/default/files/wysiwyg/funding/training-grants/eric-roberts-draft-application.pdf
May 19, 2021 - and inpatient care, and the Part D Low-Income
Subsidy (LIS), which helps to pay for prescription drugs … premiums, deductibles, and cost sharing for physician
services, hospital care, and prescription drugs … asset tests) and the Part D Low-Income Subsidy (a similarly means-tested program for prescription drugs … Donohue’s research examines
insurance and health care delivery, focusing on the use of prescription drugs … asset-limited individuals broadly curtail spending
on care—including medically necessary prescription drugs
-
www.ahrq.gov/sites/default/files/wysiwyg/patients-consumers/patient-involvement/healthy-men/healthy-men.pdf
March 01, 2014 - ■ You have ever injected drugs.
■ You received a blood transfusion before
1992.